Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
Open Access
- 11 April 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 43 (1) , 53-59
- https://doi.org/10.1016/j.jhep.2005.02.015
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The natural history and outcome of liver transplantation in hepatitis C virus-infected recipientsLiver Transplantation, 2003
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002
- Hepatitis C and liver transplantationJournal of Hepatology, 2001
- Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantationHepatology, 2000
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999
- Severe recurrent cholestatic hepatitis C following orthotopic liver transplantationHepatology, 1996
- Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantationLiver Transplantation and Surgery, 1996
- Hepatitis C Viral Infection in Liver TransplantationArchives of Surgery, 1996